Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1910 Acute Somatostatin Analog Suppression Test in a Patient with Thyrotropin-secreting Pituitary Macroadenoma

Introduction: Thyrotropin-secreting pituitary adenomas are rare and often plurihormonal tumours. The long-acting somatostatin analogues (SSA) are effective in cases not cured after surgery.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Trifanescu R, Smarandoiu A, Baciu I, Dumitrascu A, Terzea D,

Keywords: octreotide, thyrotropinoma,

#1865 Evolution of Gastroenteropancreatic Neuroendocrine Tumors – Experiene of a Romanian Endocrine Clinic

Introduction: GEP-NETs (gastroenteropancreatic neuroendocrine tumors) are a heterogenous group of tumors.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Poiana C

Authors: Baciu I, Galoiu S, Trifanescu R, Capatina C, Dumitrascu A,

Keywords: GEP-NETs,

#1549 Ectopic Cushing Syndrome in a Patient with Metastatic Medullary Thyroid Carcinoma

Introduction: Ectopic Cushing syndrome was reported in 0.6% of patients with medullary thyroid carcinoma; it usually occurred in metastatic cases and significantly increases mortality.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Poiana C

Authors: Trifanescu R, Caragheorgheopol A, Schipor S, Dumitrascu A, Baciu I,

Keywords: Ectopic Cushing syndrome, medullary thyroid carcinoma,

#25 Predictors of response to radio-embolization (TheraSphere ®) treatment of neuro-endocrine liver metastasis

Introduction: Neuroendocrine tumors (NET) frequently metastasize to the liver. Most patients have diffuse, and therefore incurable, disease. NET liver metastasis has been shown to respond to yttrium-90 microspheres therapy. This study aims to define factors that predict response to radio-embolization in patients with NET liver metastases.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Metrakos P

Authors: Metrakos P, Hassanain M, Caberera T, CHaudhury P, Dumitra S,

Keywords: radio-embolization (TheraSphere ®) treatment, neuroendocrine liver metastasis, response rate, disease bulk,